Limpag, Mildred B.

HRN: 22-07-31  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2022
CEFTRIAXONE 1G (VIAL)
10/17/2022
10/18/2022
IV
2gms
Prior To OR
For Pelvic Laparotomy With Possible Salpingectomy
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: